---
category: news
title: "Progenics Pharmaceuticals Provides Update on Reconstituted Board's Ongoing Strategic Review"
excerpt: "NEW YORK, Jan. 21, 2020 (GLOBE NEWSWIRE) -- The Board of Directors of Progenics Pharmaceuticals, Inc. PGNX, -1.07%, an oncology company developing innovative targeted medicines and artificial intelligence to find,"
publishedDateTime: 2020-01-21T20:16:00Z
webUrl: "https://www.marketwatch.com/press-release/progenics-pharmaceuticals-provides-update-on-reconstituted-boards-ongoing-strategic-review-2020-01-21-161841639"
type: article
quality: 24
heat: 24
published: false

provider:
  name: MarketWatch
  domain: marketwatch.com
  images:
    - url: "/assets/images/organizations/marketwatch.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI
  - AI in Healthcare

secured: "4XuOz822HuV5oHk/eweZFSYUw2WYQQQ/dPYE9v2PDpuBM21HaCKaACd/bFf3sNsaEe8eHAde9BbSNpGqVGvXI07FnMjt505YWT4gg/S6N3yWuyb3G2+CodQ1mQfJsHXPxVPax+XHaWamn/uVBXJ1G/kPfM8KncKBpWZsxU3mpS5NXhWP5QLVsJiZbThi+XtXLFJBbnXmNGml0yv/lL4kVYst07ELCSFDJcxlyk1gjVAVXrxpAUoE1mQc0xYI7HVPRg3wEr8ayKRRzQxYHLRQPmMm9IZccyH/CbbZqtAiKpEFULGDF6guM2sVJ28Gx/qq;aZGByqnUyR1oel+rJfK+gA=="
---

